Jamie Clark
Stock Analyst at Redburn Atlantic
(2.20)
# 2,731
Out of 4,854 analysts
5
Total ratings
80%
Success rate
1.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $144.70 | +25.78% | 2 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $253.97 | +8.67% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $174.34 | +11.85% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $152.32 | +81.20% | 1 | Oct 14, 2024 |
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $144.70
Upside: +25.78%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $253.97
Upside: +8.67%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $174.34
Upside: +11.85%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $152.32
Upside: +81.20%